Studies have shown that antibiotics are susceptible to degradation, especially in a variable climate, which leads clinicians to hesitate to use some antibiotics in OPAT settings. Dr Fekade Sime is working to address drug stability issues so that clinicians can make better decisions and be more confident about using antibiotic infusions in the community. Experts Nicolette Graham will highlight the unique requirements of OPAT in paediatric settings and Dr Conor Jamieson will explain the regulatory requirements for stability of antimicrobials in OPAT use.

Watch the recordings to hear more from speakers, including the important questions answered in the Q&A.


6.00 pm AEST   Welcome and introduction
Welcome: Prof Jason Roberts, The University of Queensland CRE REDUCE, Brisbane
Chair and moderator: Dr Fekade Sime, The University of Queensland, Brisbane

6.05 pm AEST  Antimicrobial stability studies in OPAT - highlighting challenges in tropical environments
Dr Fekade Sime, The University of Queensland Centre for Clinical Research

6.25 pm AEST   OPAT in paediatric settings - highlighting unique requirements
Ms Nicolette Graham, Queensland Children's Hospital, Brisbane

6.45 pm AEST   Regulatory requirements for stability of antimicrobials for OPAT use
Dr Conor Jamieson, Chair, Drug Stability Testing Program working group, British Society of Antimicrobial Chemotherapy

7.05 pm AEST   Questions & Answers

7.25 pm AEST,   Close

About Outpatient Parenteral Antimicrobial Therapy (OPAT), Hospital in the Home (HITH) Masterclass webinars

About Outpatient Parenteral Antimicrobial Therapy (OPAT), Hospital in the Home (HITH) Masterclass webinars

CRE RESPOND will continue its educational series on Outpatient Parenteral Antimicrobial Therapy (OPAT) / Hospital in the Home (HITH) Masterclass Series in 2024, and deliver two Masterclasses. The first masterclass will focus on HITH Models of Care, and the second theme will be announced later in the year.

The proposed dates for the 2024 masterclasses are listed below. The theme, content and speakers for each masterclass will be detailed closer to the date. Invitations will be sent out to all CRE RESPOND subscribers. Click here to subscribe and receive the invitation.

We are proud to deliver this educational and research capacity-building activity designed to connect the leaders in the field with relevant clinicians, researchers and industry across the country and abroad. OPAT in the context of HITH is increasing in popularity and use globally, and the need for information on practices and principles of its use is evident. Current trends highlight opportunities for further expansion of scope and mechanisms to provide more convenient and cost-effective care.

2024 Masterclass Dates:

  1. OPAT/HITH Masterclass 1: Thursday 29 February 2024
  2. OPAT/HITH Masterclass 2: Thursday 8 August 2024

Organising Committee

CRE RESPOND gratefully acknowledges the organisers of the OPAT / HITH Masterclass series for their contribution:

  • Dr Fekade Sime, NHMRC Emerging Leadership Fellow, Antimicrobial Optimisation, UQ Centre for Clinical Research
  • Associate Professor Benjamin Rogers, Monash Infectious Diseases and Monash Hospital in The Home, Melbourne
  • Dr James Pollard, Clinical Director of Community Care, Cabrini Health, Melbourne
  • Ms Nicolette Graham, Antimicrobial Stewardship Pharmacist, Queensland Children's Hospital
  • Mr Sean Unwin, Infectious Disease Pharmacist, The Princess Alexandra Hospital, Queensland
  • Professor Jason Roberts, Director CRE REDUCE, and NHMRC Practitioner Fellow, The University of Queensland

Program Sponsors:




Other upcoming sessions